Proceedings of the 2022 International Conference on mathematical statistics and economic analysis (MSEA 2022)

<Previous Article In Volume
Next Article In Volume>

Government Subsidy, Research and Development Investment and Profitability Evidence from Pharmaceutical Manufacturing Enterprises

Authors
Yuxuan Lian1, *, Jianfei Leng1, Yining Zhu1
1Business School, Hohai University, Nanjing, China
*Corresponding author. Email: lyx20010913@163.com
Corresponding Author
Yuxuan Lian
Available Online 29 December 2022.
DOI
10.2991/978-94-6463-042-8_78How to use a DOI?
Keywords
pharmaceutical manufacturing industry; government subsidy; R&D investment; profitability; mediating effect
Abstract

In the context of the normalization of epidemic prevention and control, the pharmaceutical manufacturing industry is facing new opportunities and challenges. Based on the panel data of 171 listed pharmaceutical manufacturing enterprises in China from 2017 to 2020, this paper uses a two-way fixed effects model to conduct an empirical study on the relationship between government subsidy, R&D investment and profitability. The results show that for the pharmaceutical manufacturing industry, government subsidy and R&D investment can significantly improve enterprise profitability; R&D investment plays a partial mediating role in the effect of government subsidy on enterprise profitability. Enterprises and government should take measures to encourage R&D investment in the pharmaceutical manufacturing industry.

Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

<Previous Article In Volume
Next Article In Volume>
Volume Title
Proceedings of the 2022 International Conference on mathematical statistics and economic analysis (MSEA 2022)
Series
Advances in Computer Science Research
Publication Date
29 December 2022
ISBN
978-94-6463-042-8
ISSN
2352-538X
DOI
10.2991/978-94-6463-042-8_78How to use a DOI?
Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

risenwbib
TY  - CONF
AU  - Yuxuan Lian
AU  - Jianfei Leng
AU  - Yining Zhu
PY  - 2022
DA  - 2022/12/29
TI  - Government Subsidy, Research and Development Investment and Profitability Evidence from Pharmaceutical Manufacturing Enterprises
BT  - Proceedings of the 2022 International Conference on mathematical statistics and economic analysis (MSEA 2022)
PB  - Atlantis Press
SP  - 544
EP  - 550
SN  - 2352-538X
UR  - https://doi.org/10.2991/978-94-6463-042-8_78
DO  - 10.2991/978-94-6463-042-8_78
ID  - Lian2022
ER  -